Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

Re: Pensions Scheme

26 Mar 2013 14:45

RNS Number : 9246A
Renold PLC
26 March 2013
 



Renold plc

("Renold" or "the Company" or "the Group")

 

Proposed UK pension scheme merger and future funding

 

Renold, a leading international supplier of industrial chains and related power transmission products, today announces that it has reached agreement with the Trustees of the UK defined benefit pension schemes to merge the schemes and put in place a new long term funding plan.

 

Scheme merger

Agreement has been reached to merge the three closed UK defined benefit pension schemes into one and to wind up the other two schemes. The merger will lead to a significant reduction in administration costs of approximately £0.5m per annum. The merger and wind up process itself is expected to be substantially complete during the first half of the next financial year.

 

Future funding basis

The merged UK pension funds will be underpinned by a 25 year asset backed partnership structure which will provide annual cash contributions of £2.5m to the pension fund, with annual increases linked to RPI and capped at 5%. The present value of this funding stream will be fully recognised as a pension fund asset in the accounts of the merged scheme and will remove £40.0m of the funding basis deficit (estimated at £63m in January 2013). The new arrangement replaces all other existing funding arrangements for the UK defined benefit schemes.

 

Impact on the Group

The underlying reduction in cash administration costs is expected to be £0.5m per annum. In order to support further investment in the business, the Trustees have also agreed to pay the first £0.5m of the remaining expenses (the Company will fund any excess each year). The expected net impact of the agreed changes is therefore a reduction in the Company's annual cash costs of £1.0m. In the first year this will be partially offset by the partnership set up costs and the costs of executing the merger itself.

 

A reduction in the gross pension assets and liabilities reported in the Group's consolidated accounts is expected once the merger is complete. However, the £40.0m asset recognised in the accounts of the merged scheme is not expected to be recognised in the Group's consolidated accounts. The new arrangements are also not expected to have a substantive net impact on the Group's tax position.

 

Robert Purcell, Chief Executive of Renold, commented:

 

"The merger of the schemes will deliver a real reduction in annual cash funding of £1.0m. The support of the UK Trustees will allow us to fund additional investment in the business and will help the new management team to deliver long term and sustainable improvement in the Group's performance for the benefit of all of our stakeholders."

 

26 March 2013

 

 

ENQUIRIES:

 

Renold plc

Tel: 0161 498 4500

Robert Purcell, Chief Executive Officer

Brian Tenner, Finance Director

Arden Partners (Broker)

Tel: 020 7614 5917

Chris Hardie

College Hill (Public Relations)

Mark Garraway

Helen Tarbet

Tel: 020 7457 2020

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on their website at: www.renold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALDKALLDEFF
Date   Source Headline
25th Aug 20217:00 amRNSHolding(s) in Company
23rd Aug 202112:11 pmRNSResult of AGM
23rd Aug 20217:00 amRNSAGM Trading Update
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
29th Jul 20214:41 pmRNSSecond Price Monitoring Extn
29th Jul 20214:36 pmRNSPrice Monitoring Extension
28th Jul 20217:00 amRNSPosting of Annual Report and Notice of AGM
27th Jul 202112:50 pmRNSDirector/PDMR Shareholding
26th Jul 20218:55 amRNSGrant of Options
19th Jul 202111:23 amRNSDirector/PDMR Shareholding
16th Jul 20217:00 amRNSFinal Results
13th Jul 20217:00 amRNSFlexible Coupling Contract Award
8th Jul 20219:47 amRNSNotice of results for the year ended 31 March 2021
23rd Jun 20213:30 pmRNSHolding(s) in Company
18th Jun 20217:00 amRNSBlock listing Six Monthly Return
16th Jun 20217:00 amRNSNotice of results for the year ended 31 March 2021
15th Jun 20214:40 pmRNSSecond Price Monitoring Extn
15th Jun 20214:35 pmRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSInvestor Presentation – 17 June 2021
28th May 202112:35 pmRNSNotice of Results
27th May 20214:02 pmRNSCapital Reduction
26th May 20218:30 amRNSPreference Stock Dividend
4th May 202110:38 amRNSHolding(s) in Company
15th Apr 20215:27 pmRNSResults of General Meeting
14th Apr 20217:00 amRNSTrading Update for the year ended 31 March 2021
29th Mar 20218:40 amRNSNotice of General Meeting
24th Feb 20215:17 pmRNSHolding(s) in Company
9th Feb 20214:37 pmRNSHolding(s) in Company
5th Feb 202112:26 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSHolding(s) in Company
13th Jan 20217:00 amRNSTrading Update
17th Dec 20207:00 amRNSBlock listing Interim Review
26th Nov 20207:00 amRNSPreference Stock Dividend
23rd Nov 20204:15 pmRNSHolding(s) in Company
20th Nov 20207:00 amRNSAppointment of Non-Executive Director
18th Nov 20204:15 pmRNSHolding(s) in Company
16th Nov 20207:00 amRNSGrant of Awards – Performance Share Plan
11th Nov 20207:00 amRNSHalf-year Report
16th Oct 20207:00 amRNSTrading Update
1st Oct 20208:41 amRNSGrant of Awards - Performance Share Plan
24th Sep 20207:00 amRNSRe: Directorate Change
22nd Sep 20203:20 pmRNSDirector/PDMR Shareholding
18th Sep 20203:50 pmRNSDirector/PDMR Shareholding
11th Aug 20207:00 amRNSPDMR/Directorate Change
24th Jul 20201:23 pmRNSResult of AGM
24th Jul 20207:00 amRNSAGM Statement
26th Jun 20202:57 pmRNSAnnual Report and Accounts
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.